BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7021159)

  • 1. Isolation of a second rifamycin-binding from Escherichia coli by affinity chromatography.
    Seydel F; Lill HR; Hartmann GR
    Eur J Biochem; 1981 Jun; 117(1):87-91. PubMed ID: 7021159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The affinity of E. coli RNA polymerase to matrix bound rifamycin.
    Scheit KH; Stütz A
    FEBS Lett; 1975 Jan; 50(1):25-7. PubMed ID: 1089069
    [No Abstract]   [Full Text] [Related]  

  • 3. The generation of the rifamycin binding site in the beta subunit of E. coli RNA polymerase through subunit interactions.
    Lowder JF; Johnson RS
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1129-36. PubMed ID: 3311043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.
    Stender W; Scheit KH
    Eur J Biochem; 1977 Jun; 76(2):591-600. PubMed ID: 330165
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of purified ribonucleic acid directed deoxyribonucleic acid polymerase of avian myeloblastosis virus and murine sarcoma-leukemia virus with a rifamycin SV derivative.
    Gurgo C; Grandgenett DP; Gerad GF; Green M
    Biochemistry; 1974 Feb; 13(4):708-13. PubMed ID: 4129863
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance and kinetic studies of the role of the divalent cation activator of RNA polymerase from Escherichia coli.
    Koren R; Mildvan S
    Biochemistry; 1977 Jan; 16(2):241-9. PubMed ID: 189795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide.
    Kono Y
    J Biochem; 1982 Jan; 91(1):381-95. PubMed ID: 6279585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycins.
    Fietta AM; Silvestri LG
    Eur J Biochem; 1975 Mar; 52(2):391-400. PubMed ID: 51795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation kinetics of complexes between the antibiotic rifamycin and DNA-dependent RNA polymerase from Escherichia coli.
    Stender W; Scheit KH
    Eur J Biochem; 1976 Jun; 65(2):333-9. PubMed ID: 780105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    Rominski A; Roditscheff A; Selchow P; Böttger EC; Sander P
    J Antimicrob Chemother; 2017 Feb; 72(2):376-384. PubMed ID: 27999011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly efficient uptake of a rifamycin derivative via the FhuA-TonB-dependent uptake route in Escherichia coli.
    Pugsley AP; Zimmerman W; Wehrli W
    J Gen Microbiol; 1987 Dec; 133(12):3505-11. PubMed ID: 3332686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and biotransformation of rifamycins in the body of experimental animals].
    Subbotina NA; Griaznova NS; Beliavskaia IV; Sazykin IuO; Navashin SM
    Antibiotiki; 1979 Aug; 24(8):590-7. PubMed ID: 485106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of biosynthetic threonine deaminase from Escherichia coli.
    Koerner K; Rahimi-Laridjani I; Grimminger H
    Biochim Biophys Acta; 1975 Jul; 397(1):220-30. PubMed ID: 1096954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of rifamycin].
    Iakovlev VP
    Antibiotiki; 1978 Jun; 23(6):526-33. PubMed ID: 677840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation in vitro of complexes between an abnormal fusion protein and the heat shock proteins from Escherichia coli and yeast mitochondria.
    Sherman MY; Goldberg AL
    J Bacteriol; 1991 Nov; 173(22):7249-56. PubMed ID: 1938919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli murein transglycosylase. Purification by affinity chromatography and interaction with polynucleotides.
    Kusser W; Schwarz U
    Eur J Biochem; 1980 Jan; 103(2):277-81. PubMed ID: 6988211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein.
    Kenwright S; Levi AJ
    Gut; 1974 Mar; 15(3):220-6. PubMed ID: 4842968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.